BIOMAT Database Logo BIOMAT Database Logo

Optimal duration of fluorouracil plus levamisole colon cancer surgical adjuvant therapy. 1996

M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd

UI MeSH Term Description Entries
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites
D017024 Chemotherapy, Adjuvant Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Adjuvant Chemotherapy,Drug Therapy, Adjuvant,Adjuvant Drug Therapy

Related Publications

M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
5-Fluorouracil plus levamisole: effective adjuvant treatment for colon cancer.
January 1990, Important advances in oncology,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Adjuvant 5-fluorouracil plus levamisole in colon cancer: the plot thickens?
June 1994, British journal of cancer,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
December 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.
December 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.
February 1990, The New England journal of medicine,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.
July 1990, The New England journal of medicine,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma.
January 1996, Clinical cancer research : an official journal of the American Association for Cancer Research,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Optimal duration of adjuvant therapy for stage III colon cancer.
May 2019, Clinical advances in hematology & oncology : H&O,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Determining the optimal duration of adjuvant therapy in colon cancer.
April 2021, Clinical advances in hematology & oncology : H&O,
M J O'Connell, and M J Kahn, and C Erlichman, and R M Goldberg, and L E Shepherd
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.
March 1995, Annals of internal medicine,
Copied contents to your clipboard!